Zu "796967-16-3" wurden 2 Artikel gefunden!
Für die Filterung wurden keine Ergebnisse gefunden!
ABT-869
Artikelnummer: Cay13653-1
ABT-869 is a dual VEGFR and PDGFR family kinase inhibitor (IC50s = 0.003, 0.004, 0.004, 0.19, 0.066, 0.003, and 0.014 µM for VEGFR1, VEGFR2, FLT3, VEGFR3, PDGFRbeta, CSF-1R, and KIT, respectively). It is selective for these kinases over other tyrosine kinases, including RET, FGFR, Src, EGFR, and c-Met (IC50s = 1.9,...
| Schlagworte: | Linifanib, N-[4-(3-amino-1H-indazol-4-yl)phenyl]-N'-(2-fluoro-5-methylphenyl)-urea |
| Anwendung: | RTK inhibitor |
| CAS | 796967-16-3 |
| MW: | 375.4 D |
ab 55,00 €
Linifanib
Artikelnummer: SYN-1002-M001
Soluble in DMSO or ethanol. Linifanib (A 741439, A-741439, A741439, ABT-869, ABT869, RG3635) is an orally active multi-targeted receptor tyrosine kinase inhibitor for the treatment of various cancers. The compound is designed to inhibit vascular endothelial growth factor and platelet-derived growth factor receptors...
| Schlagworte: | ABT-869, AL39324, RG-3635 |
| Anwendung: | PDGFR / VEFGR inhibitor |
| CAS | 796967-16-3 |
| MW: | 375,4 D |
ab 123,00 €
